NITROTRANZ

What this means for you

Registered since 20 Dec 2016. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

86098780

Registration number

5105332

Mark type

Stylized text

Filed

23 Oct 2013

Published for opposition

26 Aug 2014

Registered

20 Dec 2016

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical topical gels and ointments for transdermal delivery of analgesics, anti-inflammatories, antineoplastic agents for the treatment of cancer, muscle relaxants, anaesthetics, proteins for the treatment of wounds, growth factors for the treatment of burns, hormones, substance P antagonists for the prevention of nausea and vomiting, antifungal preparations, antivirals, antibacterial substances for medical purposes, antiobesity drugs, antianginal medications, hair growth stimulants, hair growth retardants, nutritional supplements, and antimetabolites for the treatment of cancer

Owner

• Gensco Laboratories, LLC, Doral, FL, US
• Gensco Laboratories, LLC, Doral, FL, US
• Gensco Laboratories, LLC, Miramar, FL, US

Prosecution history

• 20 Dec 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
• 30 Jan 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
• 30 Jan 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
• 17 Oct 2023 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
• 13 Jun 2023 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
• 13 Jun 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 12 Dec 2022 — TEAS SECTION 8 & 15 RECEIVED
• 20 Dec 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
• 20 Dec 2016 — REGISTERED-PRINCIPAL REGISTER
• 18 Nov 2016 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
• 17 Nov 2016 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
• 17 Nov 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 17 Nov 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 14 Nov 2016 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 28 Oct 2016 — NOTIFICATION OF NON-FINAL ACTION E-MAILED